Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
350 participants
INTERVENTIONAL
2018-12-15
2024-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Toward Zero Prescribed Opioids for Outpatient General Surgery
NCT05327777
Best Practice Alert for Opioid Prescribing
NCT04446975
Pain Control Without Opioids
NCT04813991
Postoperative Opioid Consumption After Urogyneocologic Surgery
NCT03586219
Opioid Free Anesthesia vs. Opioid Anesthesia Techniques.
NCT03367988
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators devised a prospective intervention study to eliminate or significantly reduced the use of opioids prescribed at hospital discharge after major urologic surgery.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
No opioids prescriptions at discharge
Patients will receive non-opioid analgesia, mostly over the counter, medications such as acetaminophen or ibuprofen. Opioids may be prescribed if the patients experience break through pain and call the office.
No opioids at discharge
Patients who are being scheduled for any major urologic cancer surgery (open or laparoscopic) will be counselled regarding post-operative pain and measures taken during surgery and during hospital stay.
They will be provided written information on these pain mitigation efforts and the adverse effects associated with opioids use and outpatient prescriptions.
Patients will be discharged from the hospital without any opioids prescriptions and instructions to use non-opioids analgesics.
Patients will complete a visual analog pain scale daily for 7 days after discharge from the hospital.
Patients will be able to call the clinic at anytime for any post-operative pain issues.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No opioids at discharge
Patients who are being scheduled for any major urologic cancer surgery (open or laparoscopic) will be counselled regarding post-operative pain and measures taken during surgery and during hospital stay.
They will be provided written information on these pain mitigation efforts and the adverse effects associated with opioids use and outpatient prescriptions.
Patients will be discharged from the hospital without any opioids prescriptions and instructions to use non-opioids analgesics.
Patients will complete a visual analog pain scale daily for 7 days after discharge from the hospital.
Patients will be able to call the clinic at anytime for any post-operative pain issues.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* This will include all open or laparoscopic or robotic surgery including radical prostatectomy, radical cystectomy, radical nephrectomy, partial nephrectomy, nephron-ureterectomy, and similar procedures.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Albany Medical College
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Badar M. Mian
Professor of Surgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Badar Mian, MD
Role: PRINCIPAL_INVESTIGATOR
Albany Medical College
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Albany Medical Center
Albany, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
5866
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.